Download PDF
Dtsch Med Wochenschr 2009; 134(7): 311-315
DOI: 10.1055/s-0028-1123998
Aktuelle Diagnostik & Therapie | Review article
Geburtshilfe, Hämatologie, Onkologie
© Georg Thieme Verlag KG Stuttgart · New York

Hämatologische Neoplasien und solide Tumoren in der Schwangerschaft

Teil 1: Diagnostik und grundsätzliche TherapieoptionenHematologic neoplasias and solid tumors in pregnancy Part 1: diagnosis and principal treatment optionsH. Popp1 , K. Spiekermann1 , A. Wollenberg2 , C. Spitzweg3 , B. Loehrs4
  • 1Medizinische Klinik und Poliklinik III – Großhadern, Klinikum der Universität München
  • 2Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians Universität München
  • 3Medizinische Klinik und Poliklinik II – Großhadern, Klinikum der Universität München
  • 4Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe – Großhadern, Klinikum der Universität München
Further Information

Publication History

eingereicht: 6.8.2008

akzeptiert: 2.12.1008

Publication Date:
05 February 2009 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

hämatologische Neoplasien - solide Tumoren - Schwangerschaft

Keywords

hematological neoplasias - solid tumours - pregnancy

Literatur

  • 1 Asker C, Norstedt B, Kallen B. Use of antiemetic drugs during pregnancy in Sweden.  Eur J Clin Pharmacol. 2005;  61 899-890
    Google Scholar
  • 2 Ault P, Kantarjian H, O’Brien S. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.  J Clin Oncol. 2006;  24 1204-1208
    Google Scholar
  • 3 Aviles A, Neri N. Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.  Clin Lymphoma. 2001;  2 173-177
    Google Scholar
  • 4 Aviles A, Neri N, Nambo M J. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy.  Ann Oncol. 2006;  17 286-288
    Google Scholar
  • 5 Braun-Falco O, Plewig G, Wolff H, Burgdorf W HC, Landthaler M (Hrsg). Dermatologie und Venerologie. Berlin; Springer 2005
    Google Scholar
  • 6 Briggs G G. Drugs in Pregnancy and Lactation. Baltimore; Williams & Wilkins 2005
    Google Scholar
  • 7 Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy.  Lancet Oncol. 2004;  5 283-291
    Google Scholar
  • 8 Collins J C, Liao S, Wile A G. Surgical management of breast masses in pregnant women.  J Reprod Med. 1995;  40 785-788
    Google Scholar
  • 9 De Wilde J P, Rivers A W, Price D L. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus.  Prog Biophys Mol Biol. 2005;  87 335-353
    Google Scholar
  • 10 Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy.  Pharmacol Ther. 1997;  72 207-220
    Google Scholar
  • 11 Garcia-Bournissen F, Shrim A, Koren G. Mother risk update. Safety of gadolinium during pregnancy.  Canad Family Phys. 2005;  52 309-310
    Google Scholar
  • 12 Glinoer D. et al . Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions.  J Clin Endocrinol Metab. 1991;  73 421-427
    Google Scholar
  • 13 Hahn K M, Johnson P H, Gordon N. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.  Cancer. 2006;  107 1219-26
    Google Scholar
  • 14 Johannsson O, Loman N, Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers.  Lancet. 1998;  352 1359-1360
    Google Scholar
  • 15 Leiserowitz G S. Adnexal masses in pregnancy: how often are they malignant?.  Gynecol Oncol. 2006;  101 315
    Google Scholar
  • 16 Lishner M, Zemlickis D, Degendorfer P. Maternal and fetal outcome following Hodgkin’s disease in pregnancy.  Br J Cancer. 1992;  65 114-117
    Google Scholar
  • 17 Lynch C M, Holt D A. Use of antibiotics during pregnancy.  Am Fam Physician. 1991;  43 1365-1368
    Google Scholar
  • 18 Minter A, Malik R, Ledbetter L, Winokur T, Hawn M, Saif M. Colon cancer in pregnancy.  Cancer Control. 2005;  12 196-202
    Google Scholar
  • 19 Morvillo V. et al . Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases.  Melanoma Res. 2002;  12 (6) 529-538
    Google Scholar
  • 20 Nagayama M, Watanabe Y, Nakashita S, Dodo Y. Fast MR imaging in obstetrics.  Radiographics. 2002;  22 563-582
    Google Scholar
  • 21 Oto A, Ernst R D, Hughes D, Chaljub G, Saade G. MR imaging in the triage of pregnant patients with acute abdominal and pelvic pain.  Abdom Imaging. 2008;  , epub ahead of print
    Google Scholar
  • 22 Papini E. et al . Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features.  J Clin Endocrinol Metab. 2002;  87 1941-1946
    Google Scholar
  • 23 Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy.  Haematologica. 2007;  92 1230-1237
    Google Scholar
  • 24 Pereg D, Koren G, Lishner M. Cancer in pregnancy: Gaps, challenges and solutions.  Cancer Treat Rev. 2008;  34 302-311
    Google Scholar
  • 25 Pizzuto J, Aviles A, Noriega L. Treatment of acute leukemia during pregnancy: presentation of nine cases.  Cancer Treat Rep. 1980;  64 679-683
    Google Scholar
  • 26 Pye S M, Cortes J, Ault P, Rosti G, Apperley J F. The effects of imatinib on pregnancy outcome.  Blood. 2008;  111 5505-5508
    Google Scholar
  • 27 Rudolph A M. Effects of aspirin and acetaminophen in pregnancy and in the newborn.  Arch Intern Med. 1981;  1341 358-63
    Google Scholar
  • 28 Schaefer C, Spielmann H, Vetter K. Arzneiverordnung in Schwangerschaft und Stillzeit. München; Urban & Fischer 2006
    Google Scholar
  • 29 Struve C W, Haupt S, Ohlen S. Influence of frequency of previous pregnancies on the prevalence of thyroid nodules in women without clinical evidence of thyroid disease.  Thyroid. 1993;  3 7-9
    Google Scholar
  • 30 Shen T, Vortmeyer A, Zhuang Z. High frequency of allelic loss of BRCA2 gene in pregnancy-associated breast carcinoma.  J Natl Cancer Inst. 1999;  91 1686
    Google Scholar
  • 31 Watson W J. Herceptin (trastuzumab) therapy during pregnancy: association with reversible anhydramnions.  Obstet Gynecol. 2005;  105 642
    Google Scholar
  • 32 Weisz B, Meirow D, Schiff E, Lishner M. Impact and treatment of cancer during pregnancy.  Exp Rev Anticancer Ther. 2004;  4 889-902
    Google Scholar
  • 33 Yahalom J. Treatment options for Hodgkin’s disease during pregnancy.  Leuk Lymphoma. 1990;  2 151-161
    Google Scholar

Dr. med. Henning Popp

Medizinische Klinik und Poliklinik III, Klinikum der Universität München – Großhadern

Marchioninistr. 15

81377 München

Email: Henning.Popp@med.uni-muenchen.de

      >